母乳喂养史与子宫腺肌病风险的病例对照研究
在美国西部大型医疗系统18-59岁参保者中开展病例对照研究,比较386例病理确诊子宫腺肌病病例与323例人群对照及233例子宫切除对照。与人群对照相比,曾母乳喂养者腺肌病风险降低40%(aOR 0.6,95%CI 0.3-1.0),终身母乳喂养≥12个月者aOR 0.4(95%CI 0.2-0.6)。
要点
- 曾母乳喂养与腺肌病风险降低40%相关(aOR 0.6,95%CI 0.3-1.0)。
- 母乳喂养≥8周者腺肌病风险降低(aOR 0.6,95%CI 0.4-0.8)。
- 终身母乳喂养≥12个月者腺肌病风险降低60%-70%(aOR 0.4,95%CI 0.2-0.6)。
核心结论
- 母乳喂养史与腺肌病风险降低40%相关,腺肌病可导致显著疾病负担且根治需子宫切除。
- 研究结果与既往研究一致,支持母乳喂养可能改变腺肌病风险。
研究设计与样本
- 病例对照研究,设2个对照组以解决子宫切除病例选择非病例的难题。
- 研究在华盛顿州西部大型整合医疗系统的18-59岁绝经前和绝经后参保者中进行。
- 病例为2001-2006年病理确诊的新发子宫腺肌病参保者(n=386)。
- 对照1为随机选取的年龄匹配、子宫完整的参保者(人群对照,n=323);对照2为子宫切除对照(n=233)。
- 母乳喂养史通过面对面访谈收集,分析限于至少有1次活产的参与者(病例330例、人群对照246例、子宫切除对照198例)。
主要发现
- 与人群对照相比,曾母乳喂养者腺肌病调整比值比(aOR)为0.6(95%CI 0.3-1.0),降低40%。
- 与人群对照相比,母乳喂养≥8周者aOR为0.6(95%CI 0.4-0.8)。
- 与人群对照相比,终身母乳喂养≥12个月(对照<3个月)者aOR为0.4(95%CI 0.2-0.6),降低60%。
- 与人群对照相比,终身纯母乳喂养9至<12个月(对照<3个月)者aOR为0.3(95%CI 0.2-0.6),降低70%。
- 使用子宫切除对照的分析显示相似关联模式,但幅度略减弱。
关键数值与推荐
- 曾母乳喂养:aOR 0.6(95%CI 0.3-1.0),比较病例与人群对照。
- 母乳喂养≥8周:aOR 0.6(95%CI 0.4-0.8),比较病例与人群对照。
- 终身母乳喂养≥12个月 vs <3个月:aOR 0.4(95%CI 0.2-0.6),比较病例与人群对照。
- 终身纯母乳喂养9至<12个月 vs <3个月:aOR 0.3(95%CI 0.2-0.6),比较病例与人群对照。
- 分析调整了年龄、参考年份、吸烟、教育程度和产次。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association between breastfeeding history, including lifetime exclusive breastfeeding, and risk of adenomyosis. DESIGN: We used data from a case-control study designed with 2 control groups to address the challenge of selecting noncases for a valid epidemiologic study when cases are identified by hysterectomy. The case-control study was conducted among premenopausal and postmenopausal enrollees aged 18-59 years in a large, integrated health care system in western Washington state. PATIENT(S): Cases were enrollees with incident, pathology-confirmed adenomyosis diagnosed during 2001-2006 (n = 386). The 2 control groups were as follows: (1) randomly selected age-matched enrollees with intact uteri ("population controls," n = 323) and (2) hysterectomy controls (n = 233). INTERVENTION(S): Data on breastfeeding history were collected by in-person interviews. For each reported live birth, participants were asked whether they breastfed, along with infant age at supplemental feeding introduction and breastfeeding discontinuation. MAIN OUTCOME MEASURE(S): Among participants with at least 1 live birth (330 cases, 246 population controls, and 198 hysterectomy controls), we used unconditional logistic regression to estimate adjusted odds ratios and 95% confidence intervals (CIs) for the associations between the following: (1) ever breastfeeding, (2) ever breastfeeding for ≥8 weeks, (3) lifetime breastfeeding, and (4) lifetime exclusive breastfeeding and risk of adenomyosis. Analyses were adjusted for age, reference year, smoking, education, and parity. RESULT(S): In analyses comparing cases with population controls, we observed a 40% decreased odds of adenomyosis with a history of ever breastfeeding (adjusted odds ratio, 0.6; 95% CI, 0.3-1.0) and breastfeeding for ≥8 weeks (adjusted odds ratio, 0.6; 95% CI, 0.4-0.8). The strongest associations, 60%-70% decreased odds of adenomyosis, were observed with ≥12 months of lifetime breastfeeding (vs. <3 months) (adjusted odds ratio, 0.4; 95% CI, 0.2-0.6) and 9 to <12 months of lifetime exclusive breastfeeding (vs. <3 months) (adjusted odds ratio, 0.3; 95% CI, 0.2-0.6), comparing cases to population controls. In analyses using hysterectomy controls, we observed similar patterns of associations slightly attenuated in magnitude. CONCLUSION(S): Breastfeeding history was associated with a 40% decreased odds of adenomyosis, a condition that can confer substantial morbidity and requires hysterectomy for definitive treatment. The consistency of our findings with that of a previous study lends support that breastfeeding may modify risk of adenomyosis.
引用
- Hall MS, Holt VL, Holzman C, et al. Breastfeeding history and adenomyosis risk using a novel case-control study design. Fertil Steril. 2022. PMID: 36563837. doi:10.1016/j.fertnstert.2022.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。